Plasma Metabolomics, Lipidomics, and Acylcarnitines Are Associated With Vision and Genotype but Not With Dietary Intake in Long‐Chain 3‐Hydroxyacyl‐ CoA Dehydrogenase Deficiency ( LCHADD )
Journal of Inherited Metabolic Disease · 2025
DOI: 10.1002/jimd.70060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Hak Chung und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon, USA. Hauptthemen laut MEDLINE: Carnitine, Muscular Diseases, Lipid Metabolism, Inborn Errors, Mitochondrial Trifunctional Protein. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCATS NIH HHS, NEI NIH HHS.
Abstract (Originalsprache)
3‐hydroxy acylcarnitines (3‐OH‐ACs) are key biomarkers for screening of long‐chain 3‐hydroxyacyl‐CoA dehydrogenase and trifunctional protein deficiencies (LCHADD/TFPD). The utility of this biomarker for disease monitoring in identified patients remains debated, and recent suggestions have highlighted the potential use of lipidomics for diagnosis, monitoring, prognosis, and/or identification of new biomarkers. We evaluated the use of omics in LCHADD/TFPD patients by analyzing plasma acylcarnitine profiles, metabolomics, and lipidomics, combined with genotype, visual assessments, and dietary records. Fasting plasma from 39 participants with LCHADD/TFPD and 32 control subjects were analyzed through untargeted metabolomic and lipidomic analyses. In LCHADD/TFPD participants, acylcarnitine profiling, visual and retinal function assessments were performed, and 3‐day diet records were collected. Relationships between acylcarnitines, metabolomics, lipidomics, along with visual outcomes and dietary intake were investigated. Plasma of LCHADD/TFPD participants exhibited elevated 3‐OH‐ACs, which correlated with genotype and visual outcomes. Metabolomics successfully distinguished LCHADD/TFPD from controls, and the biggest divergence was observed in lipid pathways. Metabolomic profiles tightly correlated with 3‐OH‐ACs, genotype, and visual outcomes. Lower concentrations of total lipids and some individual lipid species such as phosphoethanolamines (PE) were detected in LCHADD/TFPD, except for elevations in several certain triglycerides. LCHADD/TFPD participants followed a diet low in long‐chain fat (LCFA) as recommended. LCFA intake did not correlate with either plasma 3‐OH‐ACs or metabolomics. 3‐OH‐ACs are strong consistent biomarkers of LCHADD/TFPD that are associated with clinical parameters of vision and genotype. We did not observe a relationship between dietary LCFA intake and 3‐OH‐ACs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon, USA.
- OHSU-PSU School of Public Health, Biostatistics, Oregon Health & Science University, Portland, Oregon, USA.
- Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, USA.
- Graduate Program in Human Nutrition, Oregon Health & Science University, Portland, Oregon, USA.
- Division of Genetic and Genomic Medicine, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Melanie B Gillingham
Förderung
- NIH HHS
- NCATS NIH HHS
- NEI NIH HHS
- NICHD NIH HHS
- National Institutes of Health
Zitieren
APA
Chung, H., Choi, D., Gregor, A., Sim, E., Lau, A., Black, D., Scanga, H. L., Linshinski, A., Pennesi, M. E., Sahel, J. A., Nischal, K. K., Yang, P., Everett, L., Vockley, J., Matern, D., Harding, C. O., & Gillingham, M. B. (2025). Plasma Metabolomics, Lipidomics, and Acylcarnitines Are Associated With Vision and Genotype but Not With Dietary Intake in Long‐Chain 3‐Hydroxyacyl‐ CoA Dehydrogenase Deficiency ( LCHADD ). Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70060
Vancouver
Chung H, Choi D, Gregor A, Sim E, Lau A, Black D, et al. Plasma Metabolomics, Lipidomics, and Acylcarnitines Are Associated With Vision and Genotype but Not With Dietary Intake in Long‐Chain 3‐Hydroxyacyl‐ CoA Dehydrogenase Deficiency ( LCHADD ). Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.70060
BibTeX
@article{Chung2025,
author = {Chung, Hak and Choi, Dongseok and Gregor, Ashley and Sim, Elaine and Lau, Alison and Black, Danielle and Scanga, Hannah L and Linshinski, Angela and Pennesi, Mark E and Sahel, Jose-Alain and Nischal, Ken K and Yang, Paul and Everett, Lesley and Vockley, Jerry and Matern, Dietrich and Harding, Cary O and Gillingham, Melanie B},
title = {Plasma Metabolomics, Lipidomics, and Acylcarnitines Are Associated With Vision and Genotype but Not With Dietary Intake in Long‐Chain 3‐Hydroxyacyl‐ CoA Dehydrogenase Deficiency ( LCHADD )},
journal = {Journal of Inherited Metabolic Disease},
year = {2025},
doi = {10.1002/jimd.70060}
}
EUVIMED